NCT06019013View on ClinicalTrials.gov

A Study of QLF3108 in Participants With Advanced Solid Tumor

PHASE1RecruitingINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

August 16, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Advanced Solid Tumor
Interventions
DRUG

QLF3108

QLF3108 will be administered independent of body weight.

Trial Locations (1)

100000

RECRUITING

Chinese People's Liberation Army (PLA) General Hospital, Beijing

All Listed Sponsors
lead

Qilu Pharmaceutical Co., Ltd.

INDUSTRY